Terug
Dagbereik
€ 19,81
€ 21,68
52-Weeksbereik
€ 6,11
€ 44,60
Volume
507.360
50D / 200D Gem.
€ 22,89
/
€ 22,80
Vorige Slotkoers
€ 20,63
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,5 | 0,3 |
| P/B | 3,9 | 2,9 |
| ROE % | -136,2 | 3,7 |
| Net Margin % | -3777,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 37,00
+75.7%
Low: € 19,00
High: € 48,00
Forward WPA
-€ 4,83
Omzet Sch.
9,4 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,93
-€ 1,31 – -€ 0,36
|
510 M | 1 |
| FY2029 |
-€ 2,68
-€ 3,76 – -€ 1,04
|
310 M | 1 |
| FY2028 |
-€ 3,84
-€ 4,93 – -€ 2,04
|
160 M | 5 |
Belangrijkste Punten
Debt/Equity of 0,33 — conservative balance sheet
Negative free cash flow of -172,35M
Capital efficient — spends only 0,18% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-136,22%
ROIC-49,22%
Net Margin-3777,37%
Op. Margin-2113,85%
Veiligheid
Debt / Equity
0,33
Current Ratio5,61
Interest Coverage0,00
Waardering
P/E Ratio
-2,49
P/B Ratio3,88
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 100,00% | Revenue Growth (3Y) | -55,28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10,00M | Net Income (TTM) | -377,74M |
| ROE | -136,22% | ROA | -98,46% |
| Gross Margin | 99,44% | Operating Margin | -2113,85% |
| Net Margin | -3777,37% | Free Cash Flow (TTM) | -172,35M |
| ROIC | -49,22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,33 | Current Ratio | 5,61 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,49 | P/B Ratio | 3,88 |
| P/S Ratio | 94,02 | PEG Ratio | -0,03 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 940,18M | Enterprise Value | 909,50M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 10,00M | 5,00M | 50,00M | 0,0 |
| Net Income | -377,74M | -156,99M | -37,12M | -119,28M |
| EPS (Diluted) | -8,44 | -3,76 | -0,97 | -3,11 |
| Gross Profit | 9,94M | -134,14M | 50,00M | -61,69M |
| Operating Income | -211,39M | -163,89M | -37,15M | -76,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 383,64M | 369,97M | 68,18M | 74,58M |
| Total Liabilities | 141,50M | 57,51M | 293,90M | 266,87M |
| Shareholders' Equity | 242,14M | 312,46M | -225,72M | -192,29M |
| Total Debt | 79,96M | 1,00M | 21,11M | 1,53M |
| Cash & Equivalents | 110,64M | 319,74M | 56,86M | 67,21M |
| Current Assets | 351,17M | 355,92M | 59,80M | 68,44M |
| Current Liabilities | 62,65M | 57,29M | 23,26M | 25,97M |